INS and fatty liver disease: In addition, CR treatment improved the impaired glucose metabolism, insulin action, and dysregulation of energy metabolism in HFD-induced obese male mice, resulting in a reduction in elevated biochemical obesity parameters in plasma, as well as inhibition of hepatic steatosis in the liver and adipocyte size enlargement in fat tissue.